Definium Therapeutics, Inc.: common_shares_issued
| Value | {"unit": "shares", "value": 28126414, "concept": "us-gaap:CommonStockSharesIssued"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | Definium Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:15:01.473553+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8cd3bada-5233-4c8b-aa95-69f1b43291fd
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-22-024192 · Open the official SEC filing →Retrieved: 2026-08-19T18:15:01.473553+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001813814/common-shares-issued/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8cd3bada-5233-4c8b-aa95-69f1b43291fd
History
- supersedes {"unit": "shares", "value": 421896217, "concept": "us-gaap:CommonStockSharesIssued"} (evidence 0000950170-22-016893)